Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China
· Delayed Price · Currency is CNY 168.95
+0.20 (0.12%)
At close: Dec 5, 2025
SHA:600436 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 9,748 | 10,756 | 10,036 | 8,674 | 8,004 | 6,493 | Upgrade
|
| Other Revenue | 31.87 | 31.87 | 22.31 | 19.52 | 17.29 | 18.28 | Upgrade
|
| Revenue | 9,780 | 10,788 | 10,058 | 8,694 | 8,022 | 6,511 | Upgrade
|
| Revenue Growth (YoY) | -10.35% | 7.25% | 15.70% | 8.38% | 23.20% | 13.78% | Upgrade
|
| Cost of Revenue | 6,124 | 6,189 | 5,363 | 4,735 | 3,968 | 3,584 | Upgrade
|
| Gross Profit | 3,656 | 4,599 | 4,695 | 3,959 | 4,054 | 2,926 | Upgrade
|
| Selling, General & Admin | 845.21 | 858.09 | 1,150 | 814.41 | 1,027 | 982.2 | Upgrade
|
| Research & Development | 304.97 | 269.59 | 232.35 | 230.03 | 199.51 | 97.55 | Upgrade
|
| Other Operating Expenses | 26.95 | 48.19 | 70.77 | 71.96 | 72.05 | 53.23 | Upgrade
|
| Operating Expenses | 1,184 | 1,179 | 1,465 | 1,110 | 1,306 | 1,135 | Upgrade
|
| Operating Income | 2,472 | 3,420 | 3,230 | 2,849 | 2,748 | 1,792 | Upgrade
|
| Interest Expense | -31.29 | -37.62 | -37.31 | -38.01 | -32.9 | -27.39 | Upgrade
|
| Interest & Investment Income | 424.23 | 182.59 | 170.81 | 171.62 | 144.48 | 149.27 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.57 | 7.57 | 3.09 | 7.18 | -3.28 | -3.27 | Upgrade
|
| Other Non Operating Income (Expenses) | -14.33 | -3.03 | 6.02 | -36.47 | -21.62 | -4.4 | Upgrade
|
| EBT Excluding Unusual Items | 2,858 | 3,569 | 3,373 | 2,954 | 2,834 | 1,906 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.51 | -8.95 | 8.32 | -0.02 | 4.54 | 6.72 | Upgrade
|
| Gain (Loss) on Sale of Assets | 3.99 | 3.87 | 0.96 | 11.14 | 27.59 | 40.29 | Upgrade
|
| Asset Writedown | 1 | - | - | -0.33 | -1.02 | - | Upgrade
|
| Other Unusual Items | -25.54 | -25.54 | -13.06 | 13.18 | 3.55 | 26.08 | Upgrade
|
| Pretax Income | 2,836 | 3,539 | 3,369 | 2,978 | 2,869 | 1,979 | Upgrade
|
| Income Tax Expense | 424.7 | 543.21 | 517.77 | 454.76 | 404.23 | 289.54 | Upgrade
|
| Earnings From Continuing Operations | 2,411 | 2,996 | 2,851 | 2,523 | 2,465 | 1,689 | Upgrade
|
| Minority Interest in Earnings | 8.59 | -18.52 | -53.79 | -50.63 | -32.9 | -17.84 | Upgrade
|
| Net Income | 2,420 | 2,977 | 2,797 | 2,472 | 2,432 | 1,672 | Upgrade
|
| Net Income to Common | 2,420 | 2,977 | 2,797 | 2,472 | 2,432 | 1,672 | Upgrade
|
| Net Income Growth | -21.42% | 6.42% | 13.15% | 1.66% | 45.49% | 21.62% | Upgrade
|
| Shares Outstanding (Basic) | 603 | 604 | 603 | 603 | 603 | 603 | Upgrade
|
| Shares Outstanding (Diluted) | 603 | 604 | 603 | 603 | 603 | 603 | Upgrade
|
| Shares Change (YoY) | -0.04% | 0.16% | -0.02% | -0.07% | 0.00% | 0.11% | Upgrade
|
| EPS (Basic) | 4.01 | 4.93 | 4.64 | 4.10 | 4.03 | 2.77 | Upgrade
|
| EPS (Diluted) | 4.01 | 4.93 | 4.64 | 4.10 | 4.03 | 2.77 | Upgrade
|
| EPS Growth | -21.39% | 6.25% | 13.17% | 1.74% | 45.49% | 21.49% | Upgrade
|
| Free Cash Flow | -704.71 | 245.41 | 2,065 | 6,698 | 370.11 | 1,048 | Upgrade
|
| Free Cash Flow Per Share | -1.17 | 0.41 | 3.42 | 11.11 | 0.61 | 1.74 | Upgrade
|
| Dividend Per Share | 1.820 | 2.970 | 2.320 | 1.250 | 1.210 | 0.900 | Upgrade
|
| Dividend Growth | -47.55% | 28.02% | 85.60% | 3.31% | 34.44% | 9.76% | Upgrade
|
| Gross Margin | 37.38% | 42.63% | 46.68% | 45.54% | 50.53% | 44.95% | Upgrade
|
| Operating Margin | 25.27% | 31.70% | 32.11% | 32.77% | 34.25% | 27.52% | Upgrade
|
| Profit Margin | 24.74% | 27.60% | 27.81% | 28.44% | 30.32% | 25.67% | Upgrade
|
| Free Cash Flow Margin | -7.21% | 2.27% | 20.53% | 77.04% | 4.61% | 16.10% | Upgrade
|
| EBITDA | 2,517 | 3,475 | 3,298 | 2,897 | 2,854 | 1,882 | Upgrade
|
| EBITDA Margin | 25.74% | 32.21% | 32.79% | 33.32% | 35.58% | 28.90% | Upgrade
|
| D&A For EBITDA | 45.39 | 55 | 67.82 | 47.36 | 106.25 | 90.21 | Upgrade
|
| EBIT | 2,472 | 3,420 | 3,230 | 2,849 | 2,748 | 1,792 | Upgrade
|
| EBIT Margin | 25.27% | 31.70% | 32.11% | 32.77% | 34.25% | 27.52% | Upgrade
|
| Effective Tax Rate | 14.98% | 15.35% | 15.37% | 15.27% | 14.09% | 14.63% | Upgrade
|
| Revenue as Reported | 9,780 | 10,788 | 10,058 | 8,694 | 8,022 | 6,511 | Upgrade
|
| Advertising Expenses | - | 258.62 | 531.48 | 255.04 | 445 | 473.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.